AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05731843 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cohort 1 BEM + Ruzasvir
Description: Days 1 to 6 BEM under fasting conditions. Days 7 to 12 of BEM and Ruzasvir coadministered under fasting conditions. Days 13 to 18 of BEM and Ruzasvir coadministered under fed conditions
Study NCT05731843 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cohort 2 Ruzasvir + BEM
Description: Days 1 to 6 of Ruzasvir under fasting conditions. Days 7 to 12 of Ruzasvir and BEM coadministered under fasting conditions. Days 13 to 18 of Ruzasvir and BEM coadministered under fed conditions
Study NCT05602012 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness based cognitive counseling group
Description: Intervention: The sessions were conducted by the researchers who received training in the field of Mindfulness Based Cognitive Therapy. Sessions are structured as follows; 'Awareness and autopilot, living in our minds, tidying up the dispersed mind, recognizing the unpleasant/version, allowing, ways to take care of oneself, turning to face difficulties, being stuck in the past, living in the present?'
Study NCT05591794 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic and resistance exercises
Description: Participants in the study group will be given an aerobic exercise program on the treadmill for 8 weeks, 2 days a week, 20 minutes at a rate of 60-80% of the target heart rate. Participants will work on the treadmill for 20 minutes at 60-70% of the target heart rate for the first four weeks, and at 70-80% of the target heart rate for the last four weeks. Resistance exercises will consist of exercises that will work large muscle groups with rubber bands. According to Borg, the resistance exercises to be applied will be three sets of 10 repetitions for each movement at an RPE of 11-12 during the first four weeks, and 3 sets of 15 repetitions at the same RPE for the last four weeks, 2 times a week for 20 minutes.
Study NCT05591794 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Diet program
Description: Initially, participants will be educated on healthy eating habits through one-on-one dietitian consultation. A personalized calorie-restricting diet will be given. According to this program, the daily energy intake of the individual will be reduced to provide 0.5-1.0 kg of body weight loss per week.
Study NCT05591794 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Diet program
Description: Initially, participants will be educated on healthy eating habits through one-on-one dietitian consultation. A personalized calorie-restricting diet will be given. According to this program, the daily energy intake of the individual will be reduced to provide 0.5-1.0 kg of body weight loss per week.
Study NCT05591794 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Regular walking program
Description: Regular walking will be recommended as 30 minutes/5 days or 50 minutes/3 days per week.
Study NCT05591794 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Regular walking program
Description: Regular walking will be recommended as 30 minutes/5 days or 50 minutes/3 days per week.
Study NCT04765436 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PTX-COVID19-B
Description: Sterile solution for injection
Study NCT04765436 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.9% sodium chloride (normal saline) injection
Study NCT04824417 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Itraconazole 200 mg
Description: Control
Study NCT04824417 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Voriconazole 200mg
Description: Comparator
Study NCT05022745 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multimodal, multidisciplinary approach
Description: The patient management is adapted pre-operatively, per-operatively and post-operatively
Study NCT05022745 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Multimodal, multidisciplinary approach
Description: The patient management is adapted pre-operatively, per-operatively and post-operatively
Study NCT02201381 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metabolic treatment
Description: While subjects are being treated with the four metabolic drugs, every 3 months they will bring in their medical records and data will be collected to determine the effect of the intervention
Study NCT05436119 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Intervention: GrowBaby
Description: Virtual group educational visits will cluster women in the same trimester of pregnancy teaching trimester-specific diet and lifestyle modification, further customized to the individual using limited micronutrient and gene variant analysis. Each woman will receive base multi-nutrient and probiotic supplementation with customization if identified needs cannot be met with diet and lifestyle modification alone.
Study NCT06148571 — intervention group
Intervention type: DEVICE
Intervention: left bundle branch area pacing
Description: left bundle branch area pacing locates ventricular lead into the interventricular septum to capture left bundle branch areas.
Study NCT05445726 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CPM Device
Description: CPM device used in tangent with reference ECG for validation
Study NCT05160753 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic gastric function preserving surgery combined with resection of the anterior lymphatic drainage area
Description: A 4mL volume of double tracer is injected into the submucosa of the four quadrants of the primary tumor by intraoperative gastroscopic method., and 15 minutes after gastroscopic tracer injection, the green anterior lymph nodes were carefully dissected and removed from the surgical area and evaluated for lymph node metastasis by parallel intraoperative freezing.If all collected anterior lymph nodes are negative, laparoscopic gastric function preserving surgery will be performed.
Study NCT05160753 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparoscopic gastric function preserving surgery combined with resection of the anterior lymphatic drainage area
Description: A 4mL volume of double tracer is injected into the submucosa of the four quadrants of the primary tumor by intraoperative gastroscopic method., and 15 minutes after gastroscopic tracer injection, the green anterior lymph nodes were carefully dissected and removed from the surgical area and evaluated for lymph node metastasis by parallel intraoperative freezing.If all collected anterior lymph nodes are negative, laparoscopic gastric function preserving surgery will be performed.
Study NCT05286710 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: pharmacomechanical thrombectomy (PMT)
Description: After randomization patients will be allocated to pharmacomechanical thrombectomy (PMT) via ipsilateral popliteal venous approach or to PMT via distal calf venous approach, bail-out contralateral femoral access can be used if puncture was failed in calf vein. After PMT treatment, residual thrombus was reevaluated by ascending venography. Catheter-directed thrombolysis (CDT) was conducted if there was residual thrombus. Stenosis of iliac vein was assessed by multiangle venography and intravascular ultrasound (IVUS) was used if necessary. Percutaneous balloon angioplasty (PTA) was conducted if there was >50% stenosis of the diameter of the iliac vein. A stent was placed if the residual stenosis was >50% after PTA treatment.
Study NCT05286710 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: pharmacomechanical thrombectomy (PMT)
Description: After randomization patients will be allocated to pharmacomechanical thrombectomy (PMT) via ipsilateral popliteal venous approach or to PMT via distal calf venous approach, bail-out contralateral femoral access can be used if puncture was failed in calf vein. After PMT treatment, residual thrombus was reevaluated by ascending venography. Catheter-directed thrombolysis (CDT) was conducted if there was residual thrombus. Stenosis of iliac vein was assessed by multiangle venography and intravascular ultrasound (IVUS) was used if necessary. Percutaneous balloon angioplasty (PTA) was conducted if there was >50% stenosis of the diameter of the iliac vein. A stent was placed if the residual stenosis was >50% after PTA treatment.
Study NCT05241717 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Web-based Management of Adolescent Pain (WebMAP)
Description: Participants will be asked to complete one module per week, which are approximately 20 minutes in length. Survivors and parents will be asked to spend approximately 4.5 hours each over the course of the intervention on WebMAP including 4 hours to complete the modules and 30 minutes total corresponding with a coach. Each week, patients log into WebMAP to learn a new skill and practice that skill for 1 week to allow time for skills acquisition. WebMAP consists of two separate, password-protected programs including one for adolescents and one for parents (http://webmap2.com).
Study NCT05522894 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK104
Description: 10mg/kg IV every 3 weeks (Q3W)
Study NCT05522894 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: 75mg/m2 IV every 3 weeks (Q3W)
Study NCT05522894 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: 175mg/m2 IV every 3 weeks (Q3W)
Study NCT06362109 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Routine rehabilitation
Description: Routine rehabilitation consists of:~1. Basic treatment, including corresponding control of risk factors and education on healthy lifestyles.~2. Swallowing training, including lemon ice stimulation, empty swallowing training, and pronunciation training.~3. Pulmonary function training, including standing training, cough training, and diaphragm muscle training.
Study NCT06362109 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Routine rehabilitation
Description: Routine rehabilitation consists of:~1. Basic treatment, including corresponding control of risk factors and education on healthy lifestyles.~2. Swallowing training, including lemon ice stimulation, empty swallowing training, and pronunciation training.~3. Pulmonary function training, including standing training, cough training, and diaphragm muscle training.
Study NCT06362109 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intermittent Oro-esophageal Tube Feeding
Description: The group is given enteral nutritional support with Intermittent Oro-esophageal Tube according to the following procedure: Before each feeding, inside and outside of the tube was cleaned with water. During feeding, the patient should maintain a semi-reclining or sitting position with mouth opened, and the tube was inserted slowly and smoothly into the upper part of the esophagus by medical staffs while the appropriate depth of intubation was checked with the calibration markings on the tube wall. The distance from the incisors to the head part of the tube should be between 22-25 cm.
Study NCT04977154 — intervention group
Intervention type: OTHER
Intervention: Primary prevention
Description: The primary prevention that the trainers put in place for the hockey players
Study NCT05719051 — intervention group
Intervention type: DRUG
Intervention: Albumin infusion
Description: Albumin infusion was administrated according to the standard clinical practice
Study NCT06314529 — intervention group
Intervention type: OTHER
Intervention: Assessments
Description: Safety and efficacy assessments
Study NCT05753761 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behaviour- & Imaging-Guided Stepping Training Early Post-Stroke (BIG STEPS) intervention
Description: Using baseline accelerometry data, personalized goals of replacing sedentary time with stepping time will be developed.
Study NCT05753761 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Behaviour- & Imaging-Guided Stepping Training Early Post-Stroke (BIG STEPS) intervention
Description: Using baseline accelerometry data, personalized goals of replacing sedentary time with stepping time will be developed.
Study NCT04878614 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Levothyroxine Tablet
Description: Standard clinical management
Study NCT04878614 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levothyroxine Sodium
Description: Liquid levothyroxine through enteral feeding tube
Study NCT06461481 — intervention group
Intervention type: DEVICE
Intervention: Withings Scanwatch
Description: Data captured by the used smartwatches (Withings Scanwatch) includes activity-related data (step count, minutes in certain intensity levels), basic cardiovascular measurements such as heart rate, and sleep-related data (total time asleep, sleep efficiency and quality etc.).
Study NCT04921124 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Teriparatide
Description: PTH(1-34) cartridge and pen device
Study NCT04751292 — intervention group
Intervention type: OTHER
Intervention: Exposure to high altitude
Description: permanence at high (>2500 m) altitude; permanence is defined as being born and living at high altitude with the total time spent at lower altitudes not exceeding 2 years in the past 10 years
Study NCT05080647 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mightier online gameplay
Description: Mightier is a video-game-based biofeedback intervention that capitalizes on children's love of video games to increase emotional awareness and facilitate emotion regulation practice through heart rate (HR) control. Each family receives a Mightier Kit (Mighty Band heart rate monitor, dedicated Mightier tablet unless the family prefers to use their own device) and the Mightier App. Children wear a Mighty Band heart rate monitor on their arm while they play any one of 26+ games. As their heart rate rises the games become more difficult. For example, during a cooking game, smoke may appear on the screen and obscure the player's view. Children can either opt into an explicit cool down activity (deep breathing, progressive muscle relaxation, crossing the midline, or visualization) or cool down on their own. By simply playing Mightier, children are motivated to practice calming strategies in moments of challenge.
Study NCT05080647 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mightier online gameplay
Description: Mightier is a video-game-based biofeedback intervention that capitalizes on children's love of video games to increase emotional awareness and facilitate emotion regulation practice through heart rate (HR) control. Each family receives a Mightier Kit (Mighty Band heart rate monitor, dedicated Mightier tablet unless the family prefers to use their own device) and the Mightier App. Children wear a Mighty Band heart rate monitor on their arm while they play any one of 26+ games. As their heart rate rises the games become more difficult. For example, during a cooking game, smoke may appear on the screen and obscure the player's view. Children can either opt into an explicit cool down activity (deep breathing, progressive muscle relaxation, crossing the midline, or visualization) or cool down on their own. By simply playing Mightier, children are motivated to practice calming strategies in moments of challenge.
Study NCT06450496 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Positive parenting on-line program
Description: Positive parenting on-line program focused on parenting and personal competences relevant for parents with adolescents exhibiting mental health problems
Study NCT06024824 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Dose-Painted Intensity Modulated Radiotherapy
Description: Fifteen fractions of external beam radiation therapy (EBRT) delivered via IMRT/ VMAT.~Cohort 1 (n = 3-6) Single PTV 40.05 Gy/15#, homogenous dose. Cohort 2 (n = 3-6) High Risk PTV 45 Gy/15# SIB to PTV tumour, Elective PTV 40.05 Gy/15# to nodal regions.~Cohort 3 (n = 3-6) High risk PTV 48 Gy/15# SIB to PTV tumour, Elective PTV 40.05 Gy/15# to nodal regions.
Study NCT05549648 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Home oral excrise
Description: The current study aimed to evaluate the efficacy and user experience of mobile phone APP, a mobile application with AI component in facial movement tracking, in improving oral functions of elderly people
Study NCT05871021 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Dose escalation of radiation dose beyond the therapeutic standard
Description: Dose escalation to 75 Gy with concomitant radioprotectant bevacizumab
Study NCT04695483 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Corifollitropin alfa
Description: Controlled ovarian stimulation long-acting protocol
Study NCT04695483 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Follitropin Beta
Description: Daily controlled ovarian stimulation protocol
Study NCT04695483 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Follitropin Beta
Description: Daily controlled ovarian stimulation protocol
Study NCT04834219 — intervention group
Intervention type: PROCEDURE
Intervention: On-Pump CABG
Description: Patients who have undergone on-pump Coronary artery bypass grafting (CABG) surgery are planned by the Department of Cardiovascular Surgery.
Study NCT05298475 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Statin
Description: Medium-dose statin daily(atorvastatin 20mg qn or rosuvastatin 10mg qn)
Study NCT05298475 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PCSK9 inhibitor
Description: 1 injection of PCSK9 inhibitor once a month SC
Study NCT05298475 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PCSK9 inhibitor
Description: 1 injection of PCSK9 inhibitor twice a month SC
Study NCT04834219 — intervention group
Intervention type: PROCEDURE
Intervention: Off-Pump CABG
Description: Patients who have undergone off-pump Coronary artery bypass grafting (CABG) surgery are planned by the Department of Cardiovascular Surgery.
Study NCT05554614 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BTW app with reward-based feedback
Description: Teen drivers will be notified of their weekly driving performance via a driving safety score with information on the types of high-risk driving behaviors committed as well as progress on maintaining and/or improving weekly safe driving behaviors. Educational materials on different driving situations and scenarios associated with the high-risk driving behaviors (e.g. 90-second videos) will be provided for the driver to review at any point and time. Information on these driving behaviors and the education material will be provided via push notifications from the BTW app. Weekly leader boards will show the driver's driving safety score in comparison to other drivers of the same age. Consistently high driver safety scores in certain driving skill areas (e.g., cornering) and a total overall score above 70% of other users on that skill or total score will unlock gamification-based rewards (e.g., driving safety badges, driving safety score leader board, group challenges with winners).
Study NCT05554614 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BTW app with situational supervised driving practice
Description: Teen drivers will be provided bi-weekly push-notifications from the BTW app notifying them of situational supervised driving practice activities that are to be completed during the assigned week. There are 12 situational supervised driving activities and six skill-building driving activities (Table 1). Skill-building sessions are assigned for off weeks during the first half of the six months (weeks 2-12), allowing for skills to be further developed when the situations are encountered for a second time (weeks 15-23). Parents will be prompted to directly log situational supervised and skill-building driving activities in the app after the session within the BTW app to obtain the module completion date and duration time.
Study NCT05554614 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Sham BTW app
Description: Teens will be provided links to passive education materials and information on car maintenance every week. They will not be given feedback on their driving performances.
Study NCT04832321 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey questionnaire
Description: Each version of the questionnaire portrays a young Ugandan man with different profiles of illness severity, treatment, and treatment response.
Study NCT05713552 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Acuvue Oasys 1 Day for Astigmatism with Legacy lidstock
Description: CONTROL
Study NCT05713552 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Acuvue Oasys 1 Day for Astigmatism with Amcor laminated lidstock
Description: TEST
Study NCT06150456 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: extraction
Description: extraction: in all groups, extraction will be performed
Study NCT06150456 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: low level laser therapy
Description: extraction: in all groups, extraction will be performed Treatment with low-intensity infrared 808 nm laser therapy will be applied in 2 stages: one in the immediate postoperative period and 10 days after surgery.
Study NCT06150456 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Plenum® OSShp and Plenum® Guide
Description: extraction: in all groups, extraction will be performed Immediately after tooth extraction, the biomaterials Plenum® OSShp and Plenum® Guide (Brazil) will be added to the dental socket, serving as a bone substitute and maintaining alveolar dimensions.
Study NCT04999033 — intervention group
Intervention type: OTHER
Intervention: no intervention
Description: This is a cross-sectional study, and no intervention will be included
Study NCT04860596 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: collaborative health management model
Description: nursing education program
Study NCT04841018 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: High dose dexamethasone
Description: After caudal block with 1.2ml/kg of 0.15% ropivacaine, the patient receives 0.5mg/kg of intravenous dexamethasone
Study NCT06342570 — intervention group
Intervention type: OTHER
Intervention: There is no Intervention name to describe.
Description: There is no Intervention name to describe.